Displaying 2381 - 2400 of 4742
1602002 Informal Interpretation
Date
Rule
801.11
If a natural person has an annual statement of income and does not control any other entities - end of analysis. Whatever is on the income statement rules for purposes of determining size of person...
File
Original Image
(48.01 KB)
1602001 Informal Interpretation
Date
Rule
802.63, Size of Transaction
For purposes of calculating the size of transaction, debt that is acquired post-bankruptcy announcement and that will be cancelled/forgiven in exchange for equity in target must be included. This is...
File
Original Image
(59.78 KB)
FTC Requires Drug Marketer Hikma Pharmaceuticals PLC to Divest Rights to Five Generic Injectable Drugs as a Condition of Acquiring Certain Drug Products from Ben Venue Laboratories, Inc.
Date
The Federal Trade Commission will require generic drug marketer Hikma Pharmaceuticals PLC to divest its rights and interests in five generic injectable pharmaceuticals, as part of a settlement...
FTC Puts Conditions on Generic Drug Marketer Lupin Ltd.’s Proposed Acquisition of Gavis Pharmaceuticals LLC
Date
Generic drug manufacturers Lupin Ltd. and Gavis Pharmaceuticals LLC will sell the rights and assets for two generic drugs, one used to treat bacterial infections and the other to treat ulcerative...
Federal Antitrust Agencies Submit Joint Statement Encouraging Massachusetts to Consider Expanding Treatment Options for Glaucoma Patients
Date
In response to a request by Massachusetts State Representative Bradley H. Jones, the Federal Trade Commission and the Department of Justice’s Antitrust Division have submitted a statement encouraging...
FTC Amicus Brief Urges Appeals Court to Correct District Court Holding that Proving Injury-in-Fact Is Necessary to Establish an Antitrust Violation
Date
The Federal Trade Commission filed an amicus brief in the U.S. Court of Appeals for the First Circuit urging the court to correct the district court’s holding that a plaintiff must prove an injury-in...
In re Nexium (Esomeprazole) Antitrust Litigation
Date
Citation Number
15-2005, 15-2006, 15-2007
Federal Court
U.S. Circuit Court of Appeals for the First Circuit
Brief of the Federal Trade Commission arguing that the district court committed legal error by conflating two distinct analyses under antitrust law: the existence of an antitrust violation, which...
File
Text of the Amicus Brief
(267.26 KB)
FTC Staff: West Virginia Should Consider the Competitive Impact of Legislation Affecting Advanced Practice Registered Nurses
Date
Federal Trade Commission staff submitted written comments on the competitive impact of a legislative proposal to modify the supervision requirements imposed on Advanced Practice Registered Nurses...
FTC Submits Fiscal Year 2017 Budget Request, Performance Plan, and Fiscal Year 2015 Performance Report to Congress
Date
The Federal Trade Commission has submitted to Congress its Fiscal Year 2017 budget request, which includes the FY 2017 Budget Overview Statement, Performance Plan for FY 2016 and FY 2017, and...
FTC Announces Schedule for Reviewing Regulations
Date
As part of the Federal Trade Commission’s systematic review of all current FTC rules and guides, the agency is announcing a modified 10-year regulatory review schedule. To ensure that its rules and...
FTC Approves Final Order Preserving Competition in Three Pennsylvania Terminal Markets for Light Petroleum Products
Date
Following a public comment period, the Federal Trade Commission has approved a final order settling charges that energy investor ArcLight Energy Partners Fund VI, L.P.’s acquisition of Gulf Oil...
ArcLight Energy Partners Fund VI, L.P., In the Matter of
ArcLight Energy Partners Fund VI, L.P., agreed to divest its ownership interest in four light petroleum product terminals in Pennsylvania, to settle charges that ArcLight’s acquisition of Gulf Oil Limited Partnership from its parent company, Cumberland Farms, Inc., would likely be anticompetitive in three Pennsylvania terminal markets: Altoona, where ArcLight would own the only terminal handling gasoline and one of two terminals handling distillates; Scranton, where ArcLight would own one of two terminals handling gasoline and distillates; and Harrisburg, where ArcLight would own one of two terminals handling gasoline and one of three terminals handling distillates.
Type of Action
Administrative
Last Updated
FTC Matter/File Number
151 0149
Docket Number
C-4563
FTC Commissioner Ohlhausen Testifies Before Senate Judiciary Subcommittee Regarding Occupational Licensing and the State Action Doctrine
Date
In testimony presented to a U.S. Senate Judiciary subcommittee, the Federal Trade Commission described its competition enforcement and advocacy work relating to state regulatory boards and licensing...
Prepared Statement of the Federal Trade Commission: "License To Compete: Occupational Licensing and the State Action Doctrine," Before the Subcommittee On Antitrust, Competition Policy and Consumer Rights of the Committee on the Judiciary, US Senate
Date
By
Maureen K. Ohlhausen, Former Commissioner
Matter Number
P859910
File
Text of the Commission Testimony
(120.66 KB)
FTC Staff Comment: Proposed Dental Services Measure in Georgia Would Likely Enhance Competition and Increase Access to Care for Consumers
Date
Federal Trade Commission staff submitted a comment regarding proposed legislation that would broaden the types of settings under which Georgia dental hygienists are allowed to provide preventive care...
FTC Approves Final Order Settling Charges that Commercial Trucking Services Company Invited Competitor to Allocate Customers
Date
Following a public comment period, the Federal Trade Commission has approved a final order settling charges that Drug Testing Compliance Group, LLC, an Idaho-based company that provides drug and...
FTC Approves Final Order Preserving Competition in Worldwide Market for RF Power Amplifiers
Date
Following a public comment period, the Federal Trade Commission has approved a final order settling charges that NXP Semiconductors N.V.’s $11.8 billion acquisition of Freescale Semiconductor Ltd...
Drug Testing Compliance Group, LLC, In the Matter of
Drug Testing Compliance Group, LLC, agreed to settle charges that it illegally invited one of its competitors to enter into a customer allocation agreement in violation of Section 5 of the FTC Act. The proposed settlement prohibits DTC Group from communicating with competitors about rates or prices (although it does not bar public posting of rates). The settlement also prohibits the company from soliciting, entering into, or maintaining an agreement with any competitor to divide markets, allocate customers, or fix prices; and from urging any competitor to raise, fix, or maintain prices, or to limit or reduce service.
Type of Action
Administrative
Last Updated
FTC Matter/File Number
151 0048
Displaying 2381 - 2400 of 4742